FVQ

3-(pyridin-3-yl)prop-2-yn-1-yl alpha-D-mannopyranoside

Created:	2012-05-23
Last modified:	2020-07-17

Find Related PDB Entry
2 entries where FVQ is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	38
Chiral Atom Count	5
Bond Count	39
Aromatic Bond Count	6

2D diagram of FVQ

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3-(pyridin-3-yl)prop-2-yn-1-yl alpha-D-mannopyranoside
Synonyms	3-pyridin-3-ylprop-2-yn-1-yl alpha-D-mannopyranoside; D-MANNOSE ALPHA1O-PROPYNYL PYRIDINE; 3-(pyridin-3-yl)prop-2-yn-1-yl alpha-D-mannoside; 3-(pyridin-3-yl)prop-2-yn-1-yl D-mannoside; 3-(pyridin-3-yl)prop-2-yn-1-yl mannoside
Systematic Name (OpenEye OEToolkits)	(2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-(3-pyridin-3-ylprop-2-ynoxy)oxane-3,4,5-triol
Formula	C₁₄ H₁₇ N O₆
Molecular Weight	295.288
Type	D-SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C(#Cc1cccnc1)COC2OC(C(O)C(O)C2O)CO
SMILES	CACTVS	3.385	OC[CH]1O[CH](OCC#Cc2cccnc2)[CH](O)[CH](O)[CH]1O
SMILES	OpenEye OEToolkits	1.9.2	c1cc(cnc1)C#CCOC2C(C(C(C(O2)CO)O)O)O
Canonical SMILES	CACTVS	3.385	OC[C@H]1O[C@H](OCC#Cc2cccnc2)[C@@H](O)[C@@H](O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.9.2	c1cc(cnc1)C#CCO[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O
InChI	InChI	1.03	InChI=1S/C14H17NO6/c16-8-10-11(17)12(18)13(19)14(21-10)20-6-2-4-9-3-1-5-15-7-9/h1,3,5,7,10-14,16-19H,6,8H2/t10-,11-,12+,13+,14+/m1/s1
InChIKey	InChI	1.03	GMPRLXFHQUHVDW-DGTMBMJNSA-N

Related Resource References

Resource Name	Reference
PubChem	57339136

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.